These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Treatment of scleromyxedema with melphalan. Harris RB; Perry HO; Kyle RA; Winkelmann RK Arch Dermatol; 1979 Mar; 115(3):295-9. PubMed ID: 434843 [TBL] [Abstract][Full Text] [Related]
5. Scleromyxedema: An experience using treatment with systemic corticosteroid and review of the published work. Lin YC; Wang HC; Shen JL J Dermatol; 2006 Mar; 33(3):207-10. PubMed ID: 16620228 [TBL] [Abstract][Full Text] [Related]
9. Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis. Jablonska S; Blaszczyk M Eur J Dermatol; 1999; 9(7):551-4. PubMed ID: 10523735 [TBL] [Abstract][Full Text] [Related]
10. [Arndt-Gottron scleromyxedema and associated phenomena]. Lang E; Zabel M; Schmidt H Dermatologica; 1984; 169(1):29-35. PubMed ID: 6432594 [TBL] [Abstract][Full Text] [Related]
11. Improvement of scleromyxedema associated with isotretinoin therapy. Hisler BM; Savoy LB; Hashimoto K J Am Acad Dermatol; 1991 May; 24(5 Pt 2):854-7. PubMed ID: 2050852 [TBL] [Abstract][Full Text] [Related]
12. Dermabrasion for lichen amyloidosus. Report of a long-term study. Wong CK; Li WM Arch Dermatol; 1982 May; 118(5):302-4. PubMed ID: 7082019 [TBL] [Abstract][Full Text] [Related]
14. Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins. Wojas-Pelc A; Błaszczyk M; Glińska M; Jabłońska S J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):462-5. PubMed ID: 15987294 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment of intractable scleromyxedema with cyclosporin A. Saigoh S; Tashiro A; Fujita S; Matsui M; Shibata S; Takeshita H; Duan H; Moroi Y; Urabe K; Koga T; Furue M Dermatology; 2003; 207(4):410-1. PubMed ID: 14657639 [No Abstract] [Full Text] [Related]
16. Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis, and pretibial myxedema. Jolles S; Hughes J Int Immunopharmacol; 2006 Apr; 6(4):579-91. PubMed ID: 16504920 [TBL] [Abstract][Full Text] [Related]
17. Scleromyxedema: successful treatment of cutaneous and neurologic symptoms. Nieves DS; Bondi EE; Wallmark J; Raps EC; Seykora JT Cutis; 2000 Feb; 65(2):89-92. PubMed ID: 10696560 [TBL] [Abstract][Full Text] [Related]
18. Scleromyxedema: case for therapeutic suggestion. Vossaert K; Naeyaert JM; Mestdagh M Dermatologica; 1990; 180(3):189-90. PubMed ID: 2340934 [No Abstract] [Full Text] [Related]